Oculeve Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 32
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $125M
Latest Deal Amount

Oculeve General Information

Description

Developer of treatment for dry eye. The company is the developer of a non-invasive, nasal neurostimulation device designed to increase tear production in in patients with dry eye disease.

Contact Information

Website
www.oculeve.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Acquirer
Primary Office
  • 2 Corporate Drive
  • South San Francisco, CA 94080
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oculeve Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Aug-2015 $125M 000.00 00000 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 18-Mar-2014 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 20-Mar-2013 $7.59M $8.29M 000.00 Completed Startup
1. Early Stage VC 30-Aug-2012 $700K $700K Completed Startup
To view Oculeve’s complete valuation and funding history, request access »

Oculeve Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Oculeve’s complete cap table history, request access »

Oculeve Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of treatment for dry eye. The company is the developer of a non-invasive, nasal neurostimulation device design
Therapeutic Devices
South San Francisco, CA
32 As of 2015
000.00
0000 0000-00-00
000000&0 000.00

00000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
00000000000 0000000
Morrisville, NC
00 As of 0000
00000
000000&0 00000

0000 000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
00000000000 0000000
Carlsbad, CA
0 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oculeve Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TearScience Formerly VC-backed Morrisville, NC 00 00000 000000&0 00000
0000 0000 00000000 Formerly VC-backed Carlsbad, CA 0 000.00 000000&0 000.00
000 000000000000 Venture Capital-Backed Ann Arbor, MI 00 000.00 00000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Oculeve Board Members (5)

Name Representing Role Since
Brook Byers Ph.D Kleiner Perkins Board Member 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Oculeve Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oculeve Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
Versant Ventures Venture Capital Minority 000 0000 000000 0
To view Oculeve’s complete investors history, request access »